Nuclear Radiology: Page 74

IBA gets French OK to market Filtracis
By AuntMinnieEurope.com staff writers
French radiopharmaceutical developer IBA Molecular has received approval to market its Filtracis radiopharmaceutical kit in France.
October 27, 2010
GE's DaTscan gets European nod
By AuntMinnieEurope.com staff writers
GE Healthcare's SPECT radiopharmaceutical agent DaTscan has been recommended in updated European Federation of Neurological Societies guidelines for the diagnosis and management of Alzheimer's disease.
October 14, 2010
GE adds to molecular imaging line
By AuntMinnieEurope.com staff writers
GE Healthcare is highlighting a number of new developments with its molecular imaging portfolio at this week's European Association of Nuclear Medicine congress in Vienna.
October 11, 2010
PETNet opens new biomarker facility
By AuntMinnieEurope.com staff writers
Siemens Healthcare subsidiary PETNet Solutions has opened an imaging biomarker production facility in Madrid.
October 10, 2010
PETNet expands biomarker production
By AuntMinnieEurope.com staff writers
PETNet Solutions is expanding its imaging biomarker production capabilities in Nottingham, England, to enhance its ability to produce new biomarkers as investigational medicine products in the U.K.
October 7, 2010
Siemens debuts HD-Chest for PET/CT
By AuntMinnieEurope.com staff writers
Siemens Healthcare has introduced HD-Chest, a new technology designed to reduce blur created by respiration during PET/CT studies.
October 7, 2010
FLT-PET technique targets ovarian cancer
By AuntMinnieEurope.com staff writers
A molecular imaging technique that uses F-18 fluorothymidine (FLT) may prove useful in the early assessment of treatment response for cisplatin-resistant ovarian cancer, according to a study in the October issue of the Journal of Nuclear Medicine.
October 3, 2010
EANM issues radiation therapy rules for PET
By AuntMinnieEurope.com staff writers
The European Association of Nuclear Medicine (EANM) has released new guidelines for PET scanning in oncology radiation therapy.
September 30, 2010
Naviscan touts PEM study results
By AuntMinnieEurope.com staff writers
PET developer Naviscan is touting the results of a prospective study that concluded that positron emission mammography (PEM) and breast MRI had comparably high efficacy in detecting cancerous lesions.
September 27, 2010
MDS inks Russian Mo-99 deal
By AuntMinnieEurope.com staff writers
MDS Nordion has entered into an agreement with a Russian company to develop, market, and sell molybdenum-99 (Mo-99) radioisotopes produced in Russia.
September 22, 2010
European reactor operators form alliance
By AuntMinnieEurope.com staff writers
The Nuclear Research and Consultancy Group has joined the French Alternative Energies and Atomic Energy Commission and the Belgian Nuclear Research Centre to create the European Research Area of Experimental Reactors.
September 20, 2010
PET/CT detects early efficacy of chemo drug in NSCLC patients
By Wayne Forrest
Dutch researchers have found that FDG-PET/CT can identify early response to preoperative chemotherapy with erlotinib in most patients with non-small cell lung cancer (NSCLC), according to a study in the September issue of the Journal of Nuclear Medicine.
September 16, 2010
2010 09 16 11 29 19 815 Erlotinib Image Thumb
Previous Page
Page 74 of 90
Next Page